Labeling studies follow human stem cell therapies
September 01, 2005
Molecular imaging is playing a central role in shaping the future of cell-based therapies. Even as human studies near approval by the FDA, critical questions remain to be answered in preclinical work. Researchers rely on MI to produce those answers.